Many thanks to Peter Loyd, who recently gave a WebEx presentation on immunogenicity and dose selection entitled, "Non-clinical safety testing of biotechnology-derived products (mAbs): Study design issues PK-PD". The slide show for this presentation is now available in the 'BioSafe Powerpoint Presentations' section of this website.